James Young
Chairman presso NOVAVAX, INC.
Patrimonio netto: 335 030 $ in data 31/03/2024
Profilo
Attualmente, James F. Young occupa la posizione di presidente di Novavax, Inc. e di presidente di MedImmune Oncology, Inc. Il Dr. Young è anche nel consiglio di Sagimet Biosciences, Inc. e CannaRoyalty Corp. Nella sua carriera passata il dottor Young è stato presidente di La Jolla Capital, Inc., presidente, amministratore delegato e direttore finanziario di Targeted Microwave Solutions, Inc., presidente di ricerca e sviluppo di MedImmune LLC, direttore del dipartimento di genetica molecolare di Smith Kline & French Laboratories Ltd. e membro di facoltà alla Icah School of Medicine del Mount Sinai. James F. Young ha conseguito un dottorato presso il Baylor College of Medicine e una laurea presso la Villanova University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NOVAVAX, INC.
0.05% | 12/06/2023 | 70 090 ( 0.05% ) | 335 030 $ | 31/03/2024 |
| 12/07/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di James Young
| Società | Posizione | Inizio |
|---|---|---|
| NOVAVAX, INC. | Chairman | 20/04/2011 |
| ORIGIN HOUSE | Director/Board Member | - |
MedImmune Oncology, Inc.
 MedImmune Oncology, Inc. BiotechnologyHealth Technology MedImmune Oncology, Inc. engages in the clinical development of medicines to treat cancer. The company is headquartered in Gaithersburg, MD. | President | - |
Precedenti posizioni note di James Young
| Società | Posizione | Fine |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Director/Board Member | 13/07/2023 |
| TARGETED MICROWAVE SOLUTIONS INC. | Chief Executive Officer | 01/11/2018 |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Director/Board Member | 10/07/2013 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | - |
| XENCOR, INC. | Director/Board Member | 01/01/2008 |
Formazione di James Young
| Villanova University | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| ORTHOGONAL GLOBAL GROUP INC. | Finance |
| SAGIMET BIOSCIENCES INC. | Health Technology |
| TARGETED MICROWAVE SOLUTIONS INC. | Producer Manufacturing |
| Aziende private | 7 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arriva Pharmaceuticals is a privately held biopharmaceutical company focused on developing anti-inflammatory therapies for treating respiratory diseases. The company's areas of therapeutic focus are: hereditary emphysema, Chronic Obstructive Pulmonary Disease (COPD) including smoking-related emphysema, cystic fibrosis and other respiratory indications. Arriva’s current clinical focus is the development of Respriva™, its nebulized, recombinant alpha 1-antitrypsin for hereditary emphysema. Arriva Pharmaceuticals, Inc., is located in Alameda, California. | Health Technology |
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
Smith Kline & French Laboratories Ltd.
 Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Smith Kline & French Laboratories Ltd. manufactures pharmaceutical products. The company is headquartered in Brentford, the United Kingdom. | Health Technology |
CannaRoyalty Corp.
 CannaRoyalty Corp. Agricultural Commodities/MillingProcess Industries CannaRoyalty Corp. engages in the field of legal cannabis. The company was founded in February, 2015, and is headquartered in Ottawa, Canada. | Process Industries |
MedImmune Oncology, Inc.
MedImmune Oncology, Inc. BiotechnologyHealth Technology MedImmune Oncology, Inc. engages in the clinical development of medicines to treat cancer. The company is headquartered in Gaithersburg, MD. | Health Technology |
The Phillips Collection
 The Phillips Collection Other Consumer ServicesConsumer Services The Phillips Collection operates as an art museum that provides a collection of French impressionism and American modernism to contemporary art. The museum's collection includes works by American and European masters such as Paul Cézanne, Edgar Degas, Winslow Homer, Henri Matisse, Georgia O'Keeffe, Pablo Picasso, Mark Rothko, and Vincent van Gogh. The company was founded by Duncan Phillips and is headquartered in Washington, DC. | Consumer Services |
- Borsa valori
- Insiders
- James Young
